Pacira BioSciences
PCRX
PCRX
210 hedge funds and large institutions have $1.57B invested in Pacira BioSciences in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.23% more ownership
Funds ownership: 98.02% → 100.25% (+2.2%)
1% more funds holding
Funds holding: 208 → 210 (+2)
7% less capital invested
Capital invested by funds: $1.69B → $1.57B (-$115M)
Holders
210
Holding in Top 10
4
Calls
$9.45M
Puts
$5.23M
Top Buyers
| 1 | +$52.5M | |
| 2 | +$40.8M | |
| 3 | +$27M | |
| 4 |
D.E. Shaw & Co
New York
|
+$21.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.8M |
Top Sellers
| 1 | -$68.2M | |
| 2 | -$27.3M | |
| 3 | -$25.8M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12.6M |
| 5 |
DCM
Daruma Capital Management
New York
|
-$10.7M |